Kerry O'Connell

Joined firm 2006. Partner since 2017.

Kerry studied at the University of Manchester. She has spent time in both our London and Brussels offices and is currently based in Brussels. She is a member of the Brussels Bar (A list), as well as being qualified as a solicitor (England and Wales).

Kerry has experience of both EU and UK competition law and has acted on a number of merger, antitrust, state aid and regulatory matters.

Highlights include advising:

  • Vodafone on its acquisition of parts of Liberty Global.
  • Elanco on its acquisition of Bayer’s Animal Health Business and on the related sale of Elanco’s Osurnia product business to Dechra Pharmaceuticals.
  • S&P Global on its proposed merger with IHS Markit.
  • Allergan on its acquisition by Abbvie and Alexion on its acquisition by AstraZeneca, two of the largest recent mergers in the pharmaceutical sector.
  • Royal Dutch Shell in relation to its acquisition of BG Group.
  • Platts on the European Commission’s investigation into the manipulation of published prices for a number of oil and biofuel products
  • GSK on the formation of Galvani Bioelectronics with Verily Life Sciences
  • INEOS on its joint venture with Solvay and its joint venture with PetroChina

Kerry has been recognised by W@Competition in their list of “30 in their 30s” notable women competition practitioners and as a ‘Global Leader’ in Who’s Who Legal: Competition.